Stock THMA THIE POIN
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights THIE POIN

Equities

THMA

US88408P1075

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Thimble Point Acquisition : INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
Thimble Point Acquisition, Pear Therapeutics Close SPAC Merger; Combined Firm to Begin Trading Monday
MT
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company
BU
Pear Therapeutics, Inc. completed the acquisition of Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction.
CI
THIMBLE POINT ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
THIMBLE POINT ACQUISITION CORP. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Thimble Point Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
THIMBLE POINT ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
THIMBLE POINT ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Thimble Point Acquisition : Pear Therapeutics to Merge With Thimble Point Acquisition to Go Public, Strengthen Position in Prescription Digital Therapeutics
MT
Thimble Point Acquisition Corp and Pear Therapeutics Merger Call - Pre-recorded
FA
Thimble Point Acquisition : Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics (Form 8-K)
PU
THIMBLE POINT ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Thimble Point Acquisition : Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics
BU
Pear Therapeutics, Inc. entered into a definitive business combination agreement to acquire Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction.
CI
Thimble Point Acquisition Corp. Announces Board Appointments
CI
Thimble Point Acquisition Corp. has completed an IPO in the amount of $240 million.
CI
Thimble Point Acquisition Corp. has filed an IPO in the amount of $200 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THMA Stock
  4. News THIE POIN
  5. Highlights